Botulinum toxin in urology market is anticipated to grow at a CAGR of 6.4% during the forecast period (2023-2030). The demand for botulinum toxin is rising owing to various factors, including the aging population, a growth in the number of surgeries involving the toxin, and an increased prevalence of neurogenic urologic illnesses such refractory urine incontinence, urgency, and frequency. According to the survey of American Urological Association, in the 35 women with a mean age of 66 years who were enrolled in the study all selective bladder denervation procedures were completed successfully. During 6 months of follow-up the symptom improvement based on 3-day bladder diaries was 59% for urgency urinary incontinence (p <0.001), 59% for urinary incontinence (p <0.001), 39% for urgency (p <0.001), 9% for urinary frequency (p = 0.01) and 27% for the total urgency and frequency score (p <0.001).
Get Free Sample link @ https://www.omrglobal.com/request-sample/botulinum-toxin-in-urology-market
The global botulinum toxin in urology market is segmented on the application, and end-user. Based on the application, the market is sub-segmented into overactive bladder and neurogenic detrusor overactivity. Further, based on the end-user, the market is sub-segmented into hospitals and urology clinics. Among the end-user, the transparent film dressings sub-segment is anticipated to hold a considerable share of the market, owing to the providing complete list of medications, discussing a treatment plan, and accessibility.
full report of Botulinum Toxin in Urology Market available @ https://www.omrglobal.com/industry-reports/botulinum-toxin-in-urology-market
- Market Coverage
- Market number available for – 2023-2029
- Base year- 2022
- Forecast period- 2023-2029
- Segment Covered- By Source, By Product Type, By Applications
- Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill
- , and others
Market Segmentation
Global Botulinum Toxin in Urology Market by Application
- Overactive Bladder
- Neurogenic Detrusor Overactivity
Global Botulinum Toxin in Urology Market by End-User
- Hospitals
- Urology Clinics
Regional Analysis
- North America
- United States
- Canada
- Europe
- UK
- Germany
- Italy
- Spain
- France
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Rest of the World
Company Profiles
- Allergan PLC
- Bio-Med Pvt. Ltd.
- Biovencer Healthcare Pvt. Ltd.
- Daewoong Pharmaceutical Co., Ltd.
- Eisai Co. Ltd.
- Gufic Biosciences Ltd.
- HUGEL, Inc.
- IntechOpen Ltd.
- Kansas City Urology Care, P.A.
- Medytox Inc.
- Revance Therapeutics, Inc.
- Sun Pharmaceutical Industries Ltd.
- UroGen Pharma Ltd.
- Vensica Therapeutics
The Report Covers
- Market value data analysis of 2022 and forecast to 2030.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global botulinum toxin in urology market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/botulinum-toxin-in-urology-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
